ArticleEmerging microbes & infections2026
A bivalent inactivated influenza vaccine incorporating epitope-optimized surface proteins confers cross-protective immunity against H9N2 influenza virus.
Mengchan Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.